Marine Polysaccharides: A Source of Bioactive Molecules for Cell Therapy and Tissue Engineering

• Main Authors: Anne-Marie Fischer, Sylvia Colliec-Jouault, Dominique Helley, Karim Senni, Jessica Pereira, Farida Gueniche, Christine Delbarre-Ladrat, Corinne Sinquin, Jacqueline Ratiskol, Gaston Godeau
• Format: Article
• Language: English
• Published: MDPI AG 2011-09-01
• Series: Marine Drugs
• Subjects: marine bacteria; marine algae; exopolysaccharides; sulfated polysaccharides; structure; chemical modification; biological activity; blue biotechnology; cell therapy; tissue engineering
• Online Access: http://www.mdpi.com/1660-3397/9/9/1664/

The therapeutic potential of natural bioactive compounds such as polysaccharides, especially glycosaminoglycans, is now well documented, and this activity combined with natural biodiversity will allow the development of a new generation of therapeutics. Advances in our understanding of the biosynthesis, structure and function of complex glycans from mammalian origin have shown the crucial role of this class of molecules to modulate disease processes and the importance of a deeper knowledge of structure-activity relationships. Marine environment offers a tremendous biodiversity and original polysaccharides have been discovered presenting a great chemical diversity that is largely species specific. The study of the biological properties of the polysaccharides from marine eukaryotes and marine prokaryotes revealed that the polysaccharides from the marine environment could provide a valid alternative to traditional polysaccharides such as glycosaminoglycans. Marine polysaccharides present a real potential for natural product drug discovery and for the delivery of new marine derived products for therapeutic applications.